Test Bank for Gordis Epidemiology 6th by Celentano

Original price was: $35.00.Current price is: $26.50.

Test Bank for Gordis Epidemiology 6th by Celentano Digital Instant Download

Category:

This is completed downloadable of Test Bank for Gordis Epidemiology 6th by Celentano

Product Details:

  • ISBN-10 ‏ : ‎ 0323552293
  • ISBN-13 ‏ : ‎ 978-0275972165
  • Author:   David D Celentano ScD MHS (Author), Moyses Szklo MD (Author)

From the Department of Epidemiology at Johns Hopkins University and continuing in the tradition of award-winning educator and epidemiologist Dr. Leon Gordis, comes the fully revised 6th Edition of Gordis Epidemiology. This bestselling text provides a solid introduction to basic epidemiologic principles as well as practical applications in public health and clinical practice, highlighted by real-world examples throughout. New coverage includes expanded information on genetic epidemiology, epidemiology and public policy, and ethical and professional issues in epidemiology, providing a strong basis for understanding the role and importance of epidemiology in today’s data-driven society.

 

Table of Content:

  1. Section I The Epidemiologic Approach to Disease and Intervention
  2. Introduction
  3. Chapter 1 Introduction
  4. What Is Epidemiology?
  5. Objectives of Epidemiology
  6. Epidemiology and Prevention
  7. Epidemiology and Clinical Practice
  8. Epidemiologic Approach
  9. From Observations to Preventive Actions
  10. When the Frequency of a Disease Declines, Who Deserves the Credit?
  11. Integrating Prevention and Treatment
  12. Conclusion
  13. References
  14. Chapter 2 The Dynamics of Disease Transmission
  15. Modes of Transmission
  16. Clinical and Subclinical Disease
  17. Carrier Status
  18. Endemic, Epidemic, and Pandemic
  19. Disease Outbreaks
  20. Immunity and Susceptibility
  21. Herd Immunity
  22. Incubation Period
  23. Attack Rate
  24. Exploring Occurrence of Disease
  25. Outbreak Investigation
  26. Conclusion
  27. References
  28. Review Questions for Chapter 2
  29. Chapter 3 The Occurrence of Disease
  30. Surveillance
  31. Stages of Disease in an Individual and in a Population
  32. Measures of Morbidity
  33. Conclusion
  34. References
  35. Review Questions for Chapter 3
  36. Chapter 4 The Occurrence of Disease
  37. Measures of Mortality
  38. Comparing Mortality in Different Populations
  39. Other Measures of the Impact of Disease
  40. Conclusion
  41. References
  42. Review Questions for Chapter 4
  43. Chapter 5 Assessing the Validity and Reliability of Diagnostic and Screening Tests
  44. Biologic Variation of Human Populations
  45. Validity of Screening Tests
  46. Use of Multiple Tests
  47. Predictive Value of a Test
  48. Reliability (Repeatability) of Tests
  49. Relationship Between Validity and Reliability
  50. Conclusion
  51. References
  52. Appendices to Chapter 5
  53. Review Questions for Chapter 5
  54. Chapter 6 The Natural History of Disease
  55. Case-Fatality
  56. Person-Years
  57. Five-Year Survival
  58. Observed Survival
  59. The Kaplan-Meier Method
  60. Assumptions Made in Using Life Tables and Kaplan-Meier Method
  61. Apparent Effects on Prognosis of Improvements in Diagnosis
  62. Median Survival Time
  63. Relative Survival
  64. Generalizability of Survival Data
  65. Conclusion
  66. References
  67. Review Questions for Chapter 6
  68. Section II Using Epidemiology to Identify the Cause of Disease
  69. Introduction
  70. Chapter 7 Observational Studies
  71. Case Reports and Case Series
  72. Ecologic Studies
  73. Cross-Sectional Studies
  74. Case-Control Studies
  75. Conclusion
  76. References
  77. Review Questions for Chapter 7
  78. Chapter 8 Cohort Studies
  79. Design of a Cohort Study
  80. Selection of Study Populations
  81. Types of Cohort Studies
  82. Examples of Cohort Studies
  83. Cohort Studies for Investigating Childhood Health and Disease
  84. Potential Biases in Cohort Studies
  85. When Is a Cohort Study Warranted?
  86. Case-Control Studies Based Within a Defined Cohort
  87. Conclusion
  88. References
  89. Review Questions for Chapter 8
  90. Chapter 9 Comparing Cohort and Case-Control Studies
  91. Chapter 10 Assessing Preventive and Therapeutic Measures
  92. Selection of Subjects
  93. Allocating Subjects to Treatment Groups Without Randomization
  94. Allocating Subjects Using Randomization
  95. Data Collection on Subjects
  96. Crossover
  97. Factorial Design
  98. Noncompliance
  99. Conclusion
  100. References
  101. Chapter 11 Randomized Trials
  102. Sample Size
  103. Recruitment and Retention of Study Participants
  104. Ways of Expressing the Results of Randomized Trials
  105. Interpreting the Results of Randomized Trials
  106. Four Phases in Testing New Drugs in the United States
  107. Five Major Randomized Trials in the United States
  108. Randomized Trials for Evaluating Widely Accepted Interventions
  109. Registration of Clinical Trials
  110. Ethical Considerations
  111. Conclusion
  112. Epilogue
  113. References
  114. Review Questions for Chapters 10 and 11
  115. Chapter 12 Estimating Risk
  116. Absolute Risk
  117. How Do We Determine Whether a Certain Disease Is Associated With a Certain Exposure?
  118. Relative Risk
  119. Odds Ratio (Relative Odds)
  120. Conclusion
  121. References
  122. Review Questions for Chapter 12
  123. Appendix to Chapter 12
  124. Chapter 13 More on Risk
  125. Attributable Risk
  126. Comparison of Relative Risk and Attributable Risk
  127. Conclusion
  128. References
  129. Review Questions for Chapter 13
  130. Appendix to Chapter 13: Levin’s Formula for the Attributable Risk for the Total Population
  131. Chapter 14 From Association to Causation
  132. Approaches for Studying Disease Etiology
  133. Types of Associations
  134. Types of Causal Relationships
  135. Evidence for a Causal Relationship
  136. Guidelines for Judging Whether an Observed Association Is Causal
  137. Deriving Causal Inferences: Two Examples
  138. Modifications of the Guidelines for Causal Inferences
  139. Conclusion
  140. References
  141. Review Questions for Chapter 14
  142. Chapter 15 More on Causal Inference
  143. Bias
  144. Confounding
  145. Interaction
  146. Conclusion
  147. References
  148. Review Questions for Chapter 15
  149. Chapter 16 Identifying the Roles of Genetic and Environmental Factors in Disease Causation
  150. Traditional Genetics
  151. Complex Diseases
  152. Time Trends in Disease Incidence
  153. Linkage Analysis in Family Studies
  154. Interaction Between Genetic and Environmental Risk Factors
  155. Precision Medicine
  156. Prospects for the Future
  157. Conclusion
  158. References
  159. Review Questions for Chapter 16
  160. Glossary of Genetic Terms for Chapter 16
  161. Section III Applying Epidemiology to Evaluation and Policy
  162. Introduction
  163. Chapter 17 Using Epidemiology to Evaluate Health Services
  164. Studies of Process and Outcome
  165. Efficacy, Effectiveness, and Efficiency
  166. Measures of Outcome
  167. Comparing Epidemiologic Studies of Disease Etiology and Epidemiologic Research Evaluating Effectiveness of Health Services
  168. Evaluation Using Group Data
  169. Evaluation Using Individual Data
  170. Conclusion
  171. References
  172. Review Questions for Chapter 17
  173. Chapter 18 Epidemiologic Approach to Evaluating Screening Programs
  174. Natural History of Disease
  175. Pattern of Disease Progression
  176. Methodologic Issues
  177. Study Designs for Evaluating Screening: Nonrandomized and Randomized Studies
  178. Problems in Assessing the Sensitivity and Specificity of Screening Tests
  179. Interpreting Study Results That Show No Benefit of Screening
  180. Cost-Benefit Analysis of Screening
  181. Conclusion
  182. References
  183. Review Questions for Chapter 18
  184. Chapter 19 Epidemiology and Public Policy
  185. Epidemiology and Prevention
  186. Population Approaches Versus High-Risk Approaches to Prevention
  187. Epidemiology and Clinical Medicine: Hormone Replacement Therapy in Postmenopausal Women
  188. Risk Assessment
  189. Meta-Analysis
  190. Publication Bias
  191. Epidemiology in the Courts
  192. Sources and Impact of Uncertainty
  193. Policy Issues Regarding Risk: What Should the Objectives Be?
  194. Conclusion
  195. References
  196. Chapter 20 Ethical and Professional Issues in Epidemiology
  197. Ethical Issues in Epidemiology
  198. Investigators’ Obligations to Study Subjects
  199. Protecting Privacy and Confidentiality
  200. Access to Data
  201. Race and Ethnicity in Epidemiologic Studies
  202. Conflict of Interest
  203. Interpreting Findings
  204. Conclusion
  205. References
  206. Answers to Review Questions
  207. Index